Browsing publications by Professor Philip Home

Newcastle AuthorsTitleYearFull text
Professor Philip Home
A diabetes mellitus guideline gone wrong - the 2017 ACP update2017
Professor Philip Home
Comment on Abd El Aziz et al., A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients2017
Professor Philip Home
Comment on Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems 2005–2011. Diabetes Care 2016: 39; 363–3702017
Professor Philip Home
A clinically defined nocturnal window for analysis of hypoglycemia: New insulin glargine 300U/ML (GLA-300) in type 2 diabetes (T2DM)2016
Professor Philip Home
Clinical use of the co-formulation of insulin degludec and insulin aspart2016
Professor Philip Home
Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes2016
Professor Philip Home
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?2016
Professor Philip Home
IDegAsp (insulin degludec + insulin aspart) for the management of type 2 diabetes: current status2016
Professor Philip Home
Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin2016
Professor Philip Home
A common fallacy of observational medication studies in diabetes2015
1234567891011121314151617181920...